An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies.
about
Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71.Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication.Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPaseThe transferrin receptor and the targeted delivery of therapeutic agents against cancer.Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.Iron in multiple myeloma.A ruthenium(ii) based photosensitizer and transferrin complexes enhance photo-physical properties, cell uptake, and photodynamic therapy safety and efficacy.Theranostics for hepatocellular carcinoma with Fe3O4@ZnO nanocomposites.Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1.Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.Comparison of two functional kappa light-chain transcripts amplified from a hybridoma.Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma.Transferrin receptor 1: a target for antibody-mediated cancer therapy.Sinomenine hydrochloride enhancement of the inhibitory effects of anti-transferrin receptor antibody-dependent on the COX-2 pathway in human hepatoma cells.
P2860
Q33914771-6EA69876-6246-4B9C-83F6-CFD66E6CB70FQ36117093-D1EC0AE6-C107-4354-93C9-73A71AE0DB15Q36179308-ECA4AEFD-17B7-4F15-A358-96340D1D9C41Q36406637-50506767-75C9-4496-B5C2-6D12F01572A0Q36442636-91AC528C-21A7-4CEC-9C6B-C66D7BE7469EQ37089777-B32E8678-1C0D-4D39-826C-EA588ADD6302Q38788535-58A43D07-553A-48C2-9A1B-91F636D5E794Q38823021-1C99A5D7-4F9E-42A5-86FC-66B5A83E7850Q38847426-2FC5ABA4-0B40-4307-B86A-F75FB0725C84Q39033552-62B4CC15-67D6-45D9-9F05-4287F9715199Q39158237-075C6136-F4F5-44F8-B6AB-66DA859E0BA1Q52719493-252CCA9C-EC5F-4F5F-A519-27B97760204CQ52861419-E6C0D03B-DC89-4AC0-A33A-1B0FABD162A7Q53148114-51479F6B-939B-4E05-B0C0-8387A71CBC7B
P2860
An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An antibody-based multifaceted ...... atment of B-cell malignancies.
@en
An antibody-based multifaceted ...... atment of B-cell malignancies.
@nl
type
label
An antibody-based multifaceted ...... atment of B-cell malignancies.
@en
An antibody-based multifaceted ...... atment of B-cell malignancies.
@nl
prefLabel
An antibody-based multifaceted ...... atment of B-cell malignancies.
@en
An antibody-based multifaceted ...... atment of B-cell malignancies.
@nl
P2093
P2860
P1476
An antibody-based multifaceted ...... atment of B-cell malignancies.
@en
P2093
Benjamin Bonavida
Elizabeth Ortiz-Sánchez
Gustavo Helguera
Manuel L Penichet
Rafaela Quintero
Rosendo Luria-Pérez
Tracy R Daniels
P2860
P304
P356
10.1097/CJI.0B013E318222FFC8
P577
2011-07-01T00:00:00Z